Light Treatment to Improve Symptom Management of Fibromyalgia Syndrome

University of Michigan logo

University of Michigan

Status

Completed

Conditions

Fibromyalgia
FMS

Treatments

Device: Light therapy B (Dim) via the Re-Timer®
Device: Light therapy A (Bright) via the Re-Timer®

Study type

Interventional

Funder types

Other
NIH

Identifiers

NCT03794908
1R21NR016930-01A1 (U.S. NIH Grant/Contract)
HUM00151160

Details and patient eligibility

About

The purpose of this study is to determine the effect a morning light treatment has on improving physical function, pain intensity, and pain sensitivity in people with fibromyalgia syndrome (FMS).

Enrollment

60 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

• Meet criteria for Fibromyalgia syndrome (FMS)

Exclusion criteria

  • Significant chronic disease
  • Severe hearing or memory problems
  • Pending medical leave applications at workplace
  • Current pregnancy, breastfeeding, or actively trying to get pregnant
  • Night work or travel outside the eastern time zone within 1 month of the study
  • Other research participation
  • Frequent number of special events during study period (weddings, concerts, exams, etc).

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

60 participants in 2 patient groups

Light therapy A (Bright) via the Re-Timer®
Experimental group
Description:
60 minutes/day For the first hour after waking
Treatment:
Device: Light therapy A (Bright) via the Re-Timer®
Light therapy B (Dim) via the Re-Timer®
Active Comparator group
Description:
60 minutes/day For the first hour after waking
Treatment:
Device: Light therapy B (Dim) via the Re-Timer®

Trial documents
2

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems